Matrix Metalloprotease-9 Inhibition Improves Amyloid β-Mediated Cognitive Impairment and Neurotoxicity in Mice
Hiroyuki Mizoguchi(Nagoya University), Kiyofumi Yamada(Fujita Health University), Eiichi Someya(Kanazawa University), Daisuke Ibi(Kanazawa University), Kazuhiro Takuma(Harbin Medical University), Tursun Alkam(University of California San Diego), Hiroko Tsunekawa(Nagoya University Hospital), Toshitaka Nabeshima(Fujita Health University), Emiko Fukuzaki(Kanazawa University), Ko-hei Akazawa(Kanazawa University), Akihiro Mouri(Fujita Health University), Yukihiro Noda(Meijo University)
Cited by 83
Related Papers
Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment
|Neurochemistry International|2007|266
Blonanserin Ameliorates Phencyclidine-Induced Visual-Recognition Memory Deficits: the Complex Mechanism of Blonanserin Action Involving D3-5-HT2A and D1-NMDA Receptors in the mPFC
|Neuropsychopharmacology|2014|202
Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice
|British Journal of Pharmacology|2009|199